These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
115 related articles for article (PubMed ID: 7988055)
1. Early changes of serum N-acetyl-beta-glucosaminidase, tissue plasminogen activator and erythrocyte superoxide dismutase in relation to retinopathy in type 1 diabetes mellitus. Skrha J; Hodinár A; Kvasnicka J; Stibor V; Sperl M; Stolba P; Hilgertová J Clin Chim Acta; 1994 Sep; 229(1-2):5-14. PubMed ID: 7988055 [TBL] [Abstract][Full Text] [Related]
2. [Serum N-acetyl-beta-D-glucosaminidase (NAG) activity in patients with diabetes mellitus with reference to diabetic microangiopathy]. Gosiewska A; Kinalska I; Zarzycki W; Górska M; Borejszo I Pol Tyg Lek; 1992 Jan 6-13; 47(1-2):28-30. PubMed ID: 1409037 [TBL] [Abstract][Full Text] [Related]
3. [Changes in microcirculation and selected laboratory parameters in the early stages of diabetic microangiopathy]. Skrha J; Prázný M; Kvasnicka J; Kalvodová B Cas Lek Cesk; 2001 Jun; 140(12):370-4. PubMed ID: 11503186 [TBL] [Abstract][Full Text] [Related]
5. N-acetyl beta-D-glucosaminidase and alpha-L-fucosidase activities in relation to glycosylated hemoglobin levels and to retinopathy in diabetes. Miralles JM; Corrales JJ; Garcia-Diez LC; Cabezas JA; Reglero A Clin Chim Acta; 1982 Jun; 121(3):373-8. PubMed ID: 7105401 [TBL] [Abstract][Full Text] [Related]
6. Serum N-acetyl-beta-D-glucosaminidase profiles in type 1 diabetes secondary complications: causes of changes and significance of determination. Jovanović VB; Dimitrijević-Srecković VS; Mandić LM J Clin Lab Anal; 2008; 22(4):307-13. PubMed ID: 18623113 [TBL] [Abstract][Full Text] [Related]
7. A six-year follow-up of the relationship between N-acetyl-beta-glucosaminidase and albuminuria in relation to retinopathy. Skrha J; Haas T; Sperl M; Stibor V; Stolba P Diabet Med; 1991 Nov; 8(9):817-21. PubMed ID: 1837508 [TBL] [Abstract][Full Text] [Related]
8. Comparison of N-acetyl-beta-glucosaminidase and albuminuria with clinical finding of microangiopathy in type I diabetes mellitus. Skrha J; Perusicová J; Stolba P; Stibor V; Páv J Clin Chim Acta; 1987 Jul; 166(2-3):135-41. PubMed ID: 3621594 [TBL] [Abstract][Full Text] [Related]
10. Relationship of serum N-acetyl-beta-glucosaminidase activity to oxidative stress in diabetes mellitus. Skrha J; Hilgertová J Clin Chim Acta; 1999 Apr; 282(1-2):167-74. PubMed ID: 10340445 [TBL] [Abstract][Full Text] [Related]
11. The activity of N-acetyl-beta-D-glucosaminidase and tumor necrosis factor-alpha at early stage of diabetic retinopathy development in type 1 diabetes mellitus children. Myśliwiec M; Zorena K; Balcerska A; Myśliwska J; Lipowski P; Raczyńska K Clin Biochem; 2006 Aug; 39(8):851-6. PubMed ID: 16696964 [TBL] [Abstract][Full Text] [Related]
12. Association between urinary N-acetyl-beta-glucosaminidase and its isoenzyme patterns and microangiopathy in type 1 diabetes mellitus. Agardh CD; Agardh E; Isaksson A; Hultberg B Clin Chem; 1991 Oct; 37(10 Pt 1):1696-9. PubMed ID: 1914168 [TBL] [Abstract][Full Text] [Related]
13. beta-N-acetylglucosaminidase and beta-glucuronidase activities in insulin-dependent diabetic subjects with retinopathy. Pitkänen E; Kyllästinen M; Koivula T; Hormila P Diabetologia; 1980 Apr; 18(4):275-8. PubMed ID: 7418953 [TBL] [Abstract][Full Text] [Related]
14. Circulating tissue-type plasminogen activator and plasminogen activator inhibitor type 1 in proliferative diabetic retinopathy: a pilot study. Simpson AJ; Booth NA; Moore NR; Lewis SJ; Gray RS Acta Diabetol; 1999 Sep; 36(3):155-8. PubMed ID: 10664320 [TBL] [Abstract][Full Text] [Related]
15. Serum and urinary activities of beta-N-acetylglucosaminidase and beta-glucuronidase in diabetic patients. Perdichizzi G; Cucinotta D; Saitta A; Cavalieri A; Squadrito G Acta Diabetol Lat; 1983; 20(3):257-64. PubMed ID: 6637327 [TBL] [Abstract][Full Text] [Related]
16. [Determination of N-acetyl-glucosaminidase (NAG) in diabetic subjects]. Melosi A; Ricci F Quad Sclavo Diagn; 1983 Mar; 19(1):113-20. PubMed ID: 6675040 [TBL] [Abstract][Full Text] [Related]
17. [Selected immunologic and biochemical risk factors of the retinopathy and nephropathy development in children with diabetes mellitus type 1]. Myśliwiec M; Balcerska A; Zorena K; Myśliwska J; Nowacka M; Lipowski P; Raczyńska K Endokrynol Diabetol Chor Przemiany Materii Wieku Rozw; 2006; 12(4):269-73. PubMed ID: 17239304 [TBL] [Abstract][Full Text] [Related]
18. [Microalbumin and N-acetyl-beta-D-glucosaminidase in random spot urine samples as predictors of diabetic nephropathy in the elderly non-insulin dependent diabetic patients]. Hirai M; Nakano H; Oba K; Metori S Nihon Ika Daigaku Zasshi; 1997 Dec; 64(6):518-25. PubMed ID: 9436372 [TBL] [Abstract][Full Text] [Related]
19. [Albuminuria and N-acetyl-beta-glucosaminidase activity in a prospective study of type I diabetics]. Skrha J; Sperl M; Stolba P; Hilgertová J; Stibor V Vnitr Lek; 1993 Jul; 39(7):699-705. PubMed ID: 8372466 [TBL] [Abstract][Full Text] [Related]